Wall Street predicts approval for another ALS drug
March 21, 2023 at 10:45 AM EDT
An FDA advisory committee is set to meet this week to discuss a drug developed by Biogen and Ionis to treat a rare form of Lou Gehrig's disease.
Photography by Christophe Tomatis